Market Place
Sourcing Support
MNC`s Cancer Drug Patent Rejected, Allowing Generics Entry
23 Jan 2026 //
ECONOMICTIMES
AbbVie Shares Hit Record on Immunology Drug Exclusivity Till 2037
12 Sep 2025 //
REUTERS
AbbVie Celebrates as Skyrizi and Rinvoq Generate Billions
31 Jul 2025 //
BIOSPACE
Lupin launches first generic of Pred Forte in the US
16 Oct 2024 //
EXPRESSPHARMA
Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL
23 May 2024 //
EXPRESS PHARMA
AbbVie files patent litigation against generic Rinvoq makers
23 Nov 2023 //
FIERCE PHARMA
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
31 Oct 2022 //
ENDPTS
AbbVie Calls Retailers` Bystolic Generic Delay Claims Flawed
21 Sep 2021 //
LAW360
AbbVie Sues To Block Dr. Reddy`s Generic Leukemia Drug
27 Jul 2020 //
LAW360
AbbVie’s HCV treatment receives first for shorter treatment cycle
30 Sep 2019 //
IN-PHARMATECHNOLOGIST
Gilead’s hep C generics now own more than 20% of market
17 Sep 2019 //
FIERCE PHARMA
The top 10 all-time biggest-selling drugs by 2024
15 Aug 2019 //
FIERCE PHARMA
Dr Reddy`s launches generic testosterone gel in US market
06 May 2019 //
ECONOMIC TIMES
Patients stuck in corporate fight against generic drugs
10 Jan 2019 //
WASHINGTON POST
Velcade (Bortezomib): Millennium Pharmaceuticals vs Hetero Labs Limited
24 Nov 2018 //
PATENT LITIGATION
Novartis plans more ‘autonomy’ for Sandoz. But NO spinoff
15 Nov 2018 //
FIERCE PHARMA
Abbott, AbbVie settle TriCor marketing case for $25 million
27 Oct 2018 //
REUTERS
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
22 Oct 2018 //
RAPS
AbbVie settles Humira biosimilar dispute with Fresenius Kabi
19 Oct 2018 //
REUTERS
AbbVie Announces Resolution of HUMIRA® (adalimumab) Patent Dispute with Sandoz
12 Oct 2018 //
PR NEWSWIRE
Gilead to Sell Cheaper Versions of Drug That Sparked Cost Debate
25 Sep 2018 //
BLOOMBERG
Gilead to launch generic versions of its hepatitis drugs
24 Sep 2018 //
FDA Issues 54 New and Revised Product-Specific Guidances
13 Sep 2018 //
RAPS
CVS and Rite Aid sue AbbVie for `sham` AndroGel patent claims
22 Aug 2018 //
FIERCE PHARMA
Humira (Adalimumab) : AbbVie Inc. et al v. Sandoz Inc. et al
11 Aug 2018 //
PATENT LITIGATION
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead, Boehringer
08 Aug 2018 //
FIERCE PHARMA
I-MAK Report Calls AbbVie "The Worst Patent Offender" in Pharma
07 Aug 2018 //
CENTER FOR BIOSIMILARS
Patent abuse driving high drug prices, non-profit claims
02 Aug 2018 //
LIFESCIENCE PREVIEW
Judge strikes $140M AndroGel verdict after AbbVie appeal
06 Jul 2018 //
FIERCE PHARMA
Imbruvica®( Ibrutinib) : Acerta Pharma v. Pharmacyclics
18 Apr 2018 //
PATENT LITIGATION
Abbvies unfazed by the risk of generic humira
25 Sep 2017 //
FOOL
HUMIRA® REMICADE® (adalimumab ; infliximab): AbbVie Inc. et al v. Boehringer Ingelheim International GMBH
02 Aug 2017 //
PATENT LITIGATION
Dr Reddy’s progesterone capsules in US
21 Apr 2017 //
THE HINDUBUSINESS
Glenmark receives US FDA approval for generic Tricor Micronized capsules
10 Apr 2017 //
PHARMABIZ
Generics giant Teva join PhRMA? AbbVie, others aren`t having it
05 Jul 2016 //
FIERCE PHARMA
Par Pharmaceutical Begins Shipment of Generic AndroGel® 1%
03 Sep 2015 //
PR NEWS WIRE
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
22 Jul 2015 //
FIERCE PHARMA MARKETING
FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco
11 Mar 2015 //
RAPS
Merck Grants Free License For Pediatric HIV Drug
25 Feb 2015 //
PHILLY.COM
